All articles by Manish Kumar
Manish Kumar
Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs Trauma Screw in the US civilian hospital market
Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants
Novocure gets FDA nod for Optune Gio’s new head electrode for GBM
The Swiss oncology company will transition US Optune Gio users to new HFE arrays by mid-2025 through a controlled transition plan
Neuralink receives approval for brain chip clinical trial in Canada
The Canadian trial will assess a brain chip’s safety and functionality for helping individuals with quadriplegia control external devices through thought
Supira Medical initiates US early feasibility study (EFS) for high-risk PCI
Company expands clinical program beyond 70 patients already treated in South America FIH and Feasibility Studies
Positron Corporation partners with Upbeat Cardiology Solutions to expand cardiac PET-CT offerings
This cooperation aims to empower cardiology practices with advanced imaging technology and turnkey solutions which streamline the adoption of cardiac PET-CT imaging to deliver unparalleled healthcare to patients
THINK Surgical gets FDA nod for MOBIO implants on TMINI robotic system
The MOBIO Total Knee System has been added to THINK Surgical’s ID-HUB, enhancing the TMINI robotic system’s open platform for use in the US
Henry Schein to acquire glucose monitors supplier Acentus
Headquartered in Florida, Acentus, has an annual revenue of around $35m
ColoWatch and Bracco Diagnostics announce partnership to expand the availability of virtual colonoscopy for the early detection of colon and rectal Cancer
To learn more, visit Bracco’s booth #3300 at the Radiological Society of North America (RSNA) 2024 Annual Meeting, to be held from December 1-5 in Chicago, Illinois
Insulet announces Omnipod 5 system is now compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in US
The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods
DexCom and ŌURA partner to integrate glucose and biometric tracking
DexCom is also investing $75m in the Series D funding round of ŌURA, whose valuation has now exceeded $5bn